News
Sign up for updates
Get in touch with us
For sales enquiries
For all sales enquiries please contact the team at enquiries@exsurgo.com.
Media
For all media enquires please contact the team at pr@exsurgo.com with your contact details and request. Images and video of the Axon product are available here.
Filter
When a game is more than play
How gamification can support treatment for chronic pain and other neurological conditions Whether it’s smoking, drinking, eating unhealthy food or even mindlessly scrolling through social media, peo…
READNovember 30, 2022
Exsurgo’s Mindpower Newsletter – November 2022
Hi all, We are thrilled to share that our final trialist has completed the Active Neurofeedback Treatment phase of the New Zealand Axon trial in partnership with Auckland University of Technology (AUT…
READConfessions of a health tech entrepreneur
This article first appeared in NZBusiness Magazine. Richard Little is an inventor making traction in the treatment of chronic pain and other neurological conditions without the use of pharmaceuticals….
READNovember 14, 2022
The challenges for NZ’s booming healthtech sector
Our CEO and Co-founder Richard Little recently featured in the first of a three-part series by NBR’s Fiona Rotherham on the current challenges facing New Zealand’s healthtech sector. The key chall…
READOctober 19, 2022
The connection between chronic pain and mental health
Our CEO, Richard Little, spoke with The Nutters Club’s Hamish Williams about the connection between chronic pain and mental health. As Richard explains, when we’re experiencing chronic pa…
READOctober 6, 2022
The gendered differences of pain
Men and women respond to pain differently, according to new research published in the journal ‘Brain.’ Comparing how pain signals are transmitted to the brain via the spinal cord, research…
READSeptember 6, 2022